news aktuell GmbH

Worldwide sales of the new steam sterilizers and washer disinfectors from SCHLUMBOHM Medizin-Labor-Technologie GmbH to clinics, doctor's offices and laboratories

6.5.2021 10:05:00 CEST | news aktuell GmbH | Pressemelding

Del
SCHLUMBOHM Medizin-Labor-Technologie GmbH offer an extraordinary product portfolio with very innovative medical and laboratory devices worldwide:

Steam sterilizers, washer disinfectors, steam disinfection systems, large-volume washer-disinfectors, care combinations, bedpan washers, autoclaves, laboratory washers, functional medical furniture, medical waste treatment, operating tables, operating theater lights, traceability software, validation and accessories.

PASHION IN HEALTH

We're really good at it ... manufacturing, sales and service!

- Picture is available at AP Images (http://www.apimages.com) -

ABOUT US

As a manufacturer of steam sterilizers, washer disinfectors, care combinations, stainless steel furniture and systems for the treatment of medical waste, we supply hospitals and laboratories worldwide with our medical and laboratory technology. A total of more than 120 highly qualified employees work at our production sites in Germany and Italy.

The correct determination of requirements and the preparation of planning proposals are an absolute must. Professional project support right up to installation and commissioning is just as much a part of this as customer service, which follows on seamlessly. With our solutions you not only get technically mature systems, but also the assurance that you have a professional partner who takes care of your smooth functional processes.

An important key to our long-term success and acceptance in the market is ensuring quality, operational reliability and functionality in day-to-day operation and to harmonise these features with economic aspects.

In this context, for example, a team of over 20 service technicians is available to you 365 days a year, 24 hours a day, with an immediate service throughout Europe.

CONTACT

SCHLUMBOHM Medizin-Labor-Technologie GmbH

Headquarter

Grenzkehre 1, 21079 Hamburg, Germany

Phone: +49 40 76 91 50-0, Fax: +49 40 76 91 50-26

info@schlumbohm-medlab.com

www.schlumbohm-medlab.com

Bilder

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Slovak outlet Denník N republishes numerous false allegations about Alisher Usmanov that courts have already held to be unlawful13.3.2026 08:48:33 CET | Press release

(Hamburg, Germany - 12 March 2026) On 11 March 2026, the Slovak news outlet Denník N published an article concerning the alleged efforts of the Slovak government to secure the removal of two Russian nationals from the EU sanctions list. The article contained an extensive passage concerning our client, Mr Alisher Burkhanovich Usmanov. By letter dated 12 March 2026, Denník N was requested, in order to avoid court proceedings, to provide a cease-and-desist undertaking backed by a contractual penalty. “The article was published on the eve of the European Commission’s decision on the extension of the sanctions. It reads as if its authors had taken particular care to assemble, in a single piece, every factual allegation that courts have previously found to be unlawful,” said Mr Usmanov’s lawyer, Joachim Nikolaus Steinhöfel. The article contained a dozen such statements about Alisher Usmanov, even though these very allegations have for years been prohibited, retracted, deleted or corrected in

Ship parades, evening shows and partner region Liverpool The 837th HAMBURG PORT ANNIVERSARY with a top programme11.3.2026 14:02:16 CET | Press release

(Hamburg, 11 March 2026) From 8 to 10 May 2026, Hamburg is celebrating its 837th HAMBURG PORT ANNIVERSARY. The programme includes traditional highlights such as the arrival and departure parades and the unique tugboat ballet, as well as several evening shows and the fascinating fireworks display. The programme will be supplemented by new events on the water and on land. The Big Arrival Parade on Friday, 8 May, at 1:30 p.m. marks the start of the festivities and is always an unforgettable experience: more than 100 impressive ships sail up the Elbe right before the eyes of the spectators. The majestic tall ship, the Norwegian three-masted barque Statsraad Lehmkuhl, is particularly stunning. The floating Elbe stage in front of the Landungsbrücken is THE artistic anchor of the HAMBURG PORT ANNIVERSARY: Elbe in Concert presents visitors with rousing live music and impressive performances, creating a unique atmosphere against the backdrop of the harbour skyline at night. This year’s partner

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye